Atrial natriuretic peptide and type 2 diabetes development - Biomarker and genotype association study

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Jujić, Amra ^a,b   Nilsson, Peter M ^a,b   Engström, Gunnar ^b   Hedblad, Bo ^b   Melander, Olle ^a,b   Magnusson, Martin ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE PRECURSOR A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; FEMALE; GENE DOSAGE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGE FACTORS; ATRIAL NATRIURETIC FACTOR; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; SEX FACTORS; SWEDEN;

EID: 84896750943     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089201     Document Type: Article

References (41)

1. Levin ER, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 339:321-328 (Pubitemid 28366422)
2. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, et al. (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267:679-681
3. Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V, et al. (1995) Salt-resistant hypertension in mice lacking the guanylyl cyclase-a receptor for atrial natriuretic peptide. Nature 378:65-68
4. Newton-Cheh C, Larson MG, Vasan RS, Levy D, Bloch KD, et al. (2009) Association of common variants in nppa and nppb with circulating natriuretic peptides and blood pressure. Nat Genet 41:348-353
5. Magnusson M, Jujic A, Hedblad B, Engström G, Persson M, et al. (2012) Low plasma level of atrial natriuretic peptide predicts development of diabetes: The prospective Malmo diet and cancer study. J Clin Endocrinol Metab 97:638-645
6. Carlsson PO, Berne C, Jansson L (1998) Angiotensin ii and the endocrine pancreas: Effects on islet blood flow and insulin secretion in rats. Diabetologia 41:127-133 (Pubitemid 28088387)
7. Fliser D, Buchholz K, Haller H (2004) Antiinflammatory effects of angiotensin ii subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 110:1103-1107 (Pubitemid 39319009)
8. Henriksen EJ, Jacob S (2003) Angiotensin converting enzyme inhibitors and modulation of skeletal muscle insulin resistance. Diabetes Obes Metab 5:214-222 (Pubitemid 36806125)
9. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM (2002) Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 51:1699-1707 (Pubitemid 34564280)
10. Prasad A, Quyyumi AA (2004) Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome. Circulation 110:1507-1512 (Pubitemid 39238031)
11. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, et al. (1996) Angiotensin ii-mediated hypertension in the rat increases vascular superoxide production via membrane nadh/nadph oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97:1916-1923
12. Velloso LA, Folli F, Perego L, Saad MJ (2006) The multi-faceted cross-talk between the insulin and angiotensin ii signaling systems. Diabetes Metab Res Rev 22:98-107
13. Yvan-Charvet L, Even P, Bloch-Faure M, Guerre-Millo M, Moustaid-Moussa N, et al. (2005) Deletion of the angiotensin type 2 receptor (at2r) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 54:991-999 (Pubitemid 40446313)
14. Uehlinger DE, Weidmann P, Gnädinger MP, Hasler L, Bachmann C, et al. (1986) Increase in circulating insulin induced by atrial natriuretic peptide in normal humans. J Cardiovasc Pharmacol 8:1122-1129 (Pubitemid 17211574)
15. Verspohl EJ, Bernemann IK (1996) Atrial natriuretic peptide (anp)-induced inhibition of glucagon secretion: Mechanism of action in isolated rat pancreatic islets. Peptides 17:1023-1029 (Pubitemid 26355330)
16. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, et al. (2005) N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 46:660-666 (Pubitemid 43186736)
17. Rubattu S, Sciarretta S, Ciavarella GM, Venturelli V, De Paolis P, et al. (2007) Reduced levels of n-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass. J Hypertens 25:833-839 (Pubitemid 46402866)
18. Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, et al. (2007) Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 115:1345-1353 (Pubitemid 46648370)
19. Pfister R, Sharp S, Luben R, Welsh P, Barroso I, et al. (2011) Mendelian randomization study of b-type natriuretic peptide and type 2 diabetes: Evidence of causal association from population studies. PLoS Med 8:e1001112
20. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, et al. (2009) Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 41:666-676
21. Berglund G, Elmstahl S, Janzon L, Larsson SA (1993) The malmo diet and cancer study. Design and feasibility. J Intern Med 233:45-51
22. Li C, Engstrom G, Hedblad B, Berglund G, Janzon L (2005) Blood pressure control and risk of stroke: A population-based prospective cohort study. Stroke 36:725-730
23. Manjer J, Carlsson S, Elmsta° hl S, Gullberg B, Janzon L, et al. (2001) The Malmo diet and cancer study: Representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 10:489-499 (Pubitemid 34048904)
24. Persson M, Hedblad B, Nelson JJ, Berglund G (2007) Elevated lp-pla2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects. Arterioscler Thromb Vasc Biol 27:1411-1416 (Pubitemid 46823453)
25. Enhörning S, Bankir L, Bouby N, Struck J, Hedblad B, et al (2013) Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: The prospective malmo diet and cancer study cardiovascular cohort. Int J Obes (Lond) 37:598-603
26. Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Nilsson PM, et al. (2008) Risk prediction of cardiovascular disease in type 2 diabetes: A risk equation from the swedish national diabetes register. Diabetes Care 31:2038-2043
27. Lindholm E, Agardh E, Tuomi T, Groop L, Agardh CD (2001) Classifying diabetes according to the new who clinical stages. Eur J Epidemiol 17:983-989
28. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim J-L, et al (2011) External review and validation of the swedish national inpatient register. BMC Public Health 11:450
29. National Board of Health and Welfare (2003) A finger on the pulse. Monitoring public health and social conditions in sweden 1992-2002. Stockholm.
30. Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, et al (2007) The new swedish prescribed drug register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16:726-735 (Pubitemid 47180362)
31. Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, et al. (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359:2220-2232
32. Salomaa V, Havulinna A, Saarela O, Zeller T, Jousilahti P, et al. (2010) Thirty-one novel biomarkers as predictors for clinically incident diabetes. PLoS One 5:e10100
33. Ellis KL, Newton-Cheh C, Wang TJ, Frampton CM, Doughty RN, et al. (2011) Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes. J Mol Cell Cardiol 50:695-701
34. Cannone V, Boerrigter G, Cataliotti A, Costello-Boerrigter LC, Olson TM, et al. (2011) A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community. J Am Coll Cardiol 58:629-636
35. Magnusson M, Melander O, Israelsson B, Grubb A, Groop L, et al. (2004) Elevated plasma levels of nt-probnp in patients with type 2 diabetes without overt cardiovascular disease. Diabetes Care 27:1929-1935 (Pubitemid 38989234)
36. Yandle TG. (1994) Biochemistry of natriuretic peptides. J Intern Med 235:561-576
37. Hammerer-Lercher A, Ludwig W, Falkensammer G, Müller S, Neubauer E, et al. (2004) Natriuretic peptides as markers of mild forms of left ventricular dysfunction: Effects of assays on diagnostic performance of markers. Clin Chem 50:1174-1183 (Pubitemid 38828285)
38. Jujic A, Leosdottir M, Ostling G, Gudmundsson P, Nilsson P, et al. (2013) A genetic variant of the atrial natriuretic peptide gene is associated with left ventricular hypertrophy in a non-diabetic population - the Malmo preventive project study. BMC Med Genet 24;14(1):64
39. Cannone V, Cefalu' AB, Noto D, Scott CG, Bailey KR, et al. (2013) The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population. Diabetes Care 36(9):2850-6
40. Arora P, Wu C, Khan AM, Bloch DB, Davis-Dusenbery BN, et al. (2013) Atrial natriuretic peptide is negatively regulated by microRNA-425. J Clin Invest 123(8):3378-82.
41. Gale EA, Gillespie KM (2001) Diabetes and gender. Diabetologia 44(1):3-15. (Pubitemid 32141879)